Alpha-Defensin vs Thymosin Alpha-1

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Alpha-Defensin

Alpha-defensins are small cationic peptides that are key components of the innate immune system. They have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses.

Full details →

Thymosin Alpha-1

Thymosin Alpha-1 is a peptide naturally produced by the thymus gland that plays a crucial role in immune system modulation. It is approved in over 35 countries for various conditions including hepatitis B and C.

Full details →

Side-by-Side Comparison

Aspect	Alpha-Defensin	Thymosin Alpha-1
Dose Range	100 mcg–500 mcg	1.6 mg–3.2 mg
Frequency	1x daily	Less than daily
Cycle Length	2–4 weeks	4–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	Insert into microbial membranes to form pores, leading to cell death. Also have immunomodulatory effects including chemotaxis of immune cells and cytokine modulation.	Enhances T-cell function and maturation, stimulates dendritic cell activity, and modulates cytokine production. Promotes the differentiation of stem cells into mature T lymphocytes.
Typical Dosage	Research compound - dosing varies by application. Typically studied in laboratory and early clinical research settings rather than for general use.	Clinical dosing typically ranges from 1.6mg to 6.4mg administered subcutaneously 2-3 times weekly. Research protocols may vary.
Administration	Various routes studied including topical, local injection, and systemic administration depending on application.	Subcutaneous injection. Often used in cycles or as part of comprehensive immune support protocols.
Side Effects	Limited human use data. May cause local inflammation. Potential for immune activation effects.	Generally well-tolerated. Rare side effects include injection site reactions, mild flu-like symptoms, and temporary fatigue.
Best For	Recovery & Healing Immune Support	Recovery & Healing